Orexigen Therapeutics, Inc. — Form D
Orexigen Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-03. The offering totals $49.6M, of which $49.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-03-03
- Form: D
- Accession: 0001599949-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $49.6M
- Amount sold: $49.6M
- Investors: 9
- Date of first sale: 2017-02-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-281701
Issuer
- Name: Orexigen Therapeutics, Inc.
- CIK: 0001382911
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3344 N. TORREY PINES CT., LA JOLLA, CA, 92037
- Phone: (858) 875-8600
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Louis C Bock | Director | La Jolla, CA |
| Brian H Dovey | Director | La Jolla, CA |
| David J Endicott | Director | La Jolla, CA |
| Peter K Honig | Director | La Jolla, CA |
| Deborah S Jorn | Director | La Jolla, CA |
| Patrick J Mahaffy | Director | La Jolla, CA |
| Michael Narachi | Director | La Jolla, CA |
| Lota S Zoth | Director | La Jolla, CA |
| Thomas Cannell | Executive Officer | La Jolla, CA |
| Peter Flynn | Executive Officer | La Jolla, CA |
| Jason S Keyes | Executive Officer | La Jolla, CA |
| Thomas Lynch | Executive Officer | San Diego, CA |
| Michael Narachi | Executive Officer | La Jolla, CA |
| Joseph Hagan | Executive Officer | NASHVILLE, TN |
| Preston Klassen | Executive Officer | Seattle, WA |
| Eckard S Weber | Director | La Jolla, CA |
| Heather Ace | Executive Officer | La Jolla, CA |
| Wendy L Dixon | Director | La Jolla, CA |
Other filings by this issuer (2)
More